Physician profile
Michael Moon
NPI 1619014230
$6,687.94
in general payments reported to CMS, 2019-2025
54 companies · $435 in 2025
The $435 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,612 · 2020: $872 · 2021: $1,077 · 2022: $743 · 2023: $1,351 · 2024: $599 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,182 · Travel and Lodging: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,181.66 |
| Travel and Lodging | $202.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $816.47 | 2019-2025 | Belbuca |
| Electronic Waveform Lab, INC. | $682.78 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $632.15 | 2019-2023 | Ztlido |
| Atricure, INC. | $413.73 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $396.45 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16 |
| Grt US Holding, INC. | $284.81 | 2020-2021 | |
| Centinel Spine, LLC | $280.30 | 2019-2025 | Prodisc L |
| Biodelivery Sciences International, INC. | $229.06 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $204.50 | 2023-2024 | Relistor |
| Arbor Pharmaceuticals, INC. | $201.00 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $188.92 | 2021 | |
| Pfizer INC. | $171.85 | 2019-2024 | |
| Abbott Laboratories | $168.75 | 2019-2023 | Octrode |
| Lundbeck LLC | $142.54 | 2022 | |
| Vision Quest Industries INC. | $141.65 | 2023-2024 | Avid Ct2 Nmes/Ifc Stimulator |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $139.04 | 2023 | |
| Nevro Corp. | $124.65 | 2019-2024 | Senza |
| Neuronetics, INC. | $108.90 | 2020-2022 | |
| Lilly USA, LLC | $105.60 | 2019-2023 | Reyvow, Emgality |
| Stimwave Technologies Incorporated | $96.92 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $90.85 | 2022 | |
| Daiichi Sankyo INC. | $81.20 | 2019 | |
| Sentynl Therapeutics, INC. | $78.29 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $60.16 | 2019 | |
| Medtronic, INC. | $59.24 | 2025 | Inceptiv, Kyphon Express II Kyphopak Tray, Accurian |
| Abbvie INC. | $55.00 | 2019-2023 | |
| Curonix LLC | $54.71 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Eisai INC. | $50.24 | 2021 | |
| Assertio Therapeutics, INC. | $45.79 | 2019 | |
| Impel Pharmaceuticals INC. | $44.95 | 2023 | Trudhesa |
| Ermi LLC | $42.12 | 2019 | |
| Shionogi INC | $39.12 | 2019 | |
| Merz Pharmaceuticals, LLC | $39.10 | 2023 | Xeomin |
| Nalu Medical, INC. | $34.06 | 2024 | Nalu Neurostimulation System |
| Merz North America, INC. | $33.51 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $33.30 | 2025 | |
| Redhill Biopharma INC. | $32.79 | 2020-2021 | |
| Painteq LLC | $32.51 | 2021-2023 | Painteq |
| Impel Pharmaceuticals LLC | $21.29 | 2024 | Trudhesa |
| Zimmer Biomet Holdings, INC. | $21.21 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Ibsa Pharma INC. | $20.86 | 2020 | |
| Globus Medical, INC. | $20.32 | 2025 | Senza |
| Spr Therapeutics, INC | $20.00 | 2022 | |
| Forte Bio-Pharma LLC | $17.43 | 2023 | Prolate, Nalocet |
| Medline Industries Lp | $17.33 | 2019 | |
| Kaleo, INC. | $17.16 | 2019 | |
| Biogen, INC. | $15.97 | 2021 | |
| Spinal Simplicity, LLC | $14.84 | 2023 | Ha Minuteman G3-R |
| Horizon Therapeutics Plc | $14.23 | 2019 | |
| Almatica Pharma LLC | $13.25 | 2021 | |
| Indivior INC. | $12.88 | 2021 | |
| Bioventus LLC | $12.54 | 2022 | |
| Si-Bone, INC. | $6.18 | 2020 | |
| Fidia Pharma USA INC. | $5.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.